Northern Exposure PR

We are the leading public relations company serving the life science, pharmaceutical and technology industries.

Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.

Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management

Northern Exposure Public Relations  is uniquely skilled in assisting clients in all public relations requirements

Meet Our Team

hac

Richard Kerns

Richard Kerns

Managing Director

Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.

Edward Dutton

Edward Dutton

Vice President

Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.

Sarah Houlton

Sarah Houlton

Technical Consultant in Residence

Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.

Our Services

NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:

Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more. 

Contact us today to find out how we can assist you

Our Clients

Client News

06/01/2020 Cambrex Announces Management Changes and Board Appointments

07/01/2020 Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy

14/01/2020 Catalent Launches FlexDirect™ Direct-to-Patient Clinical Supply Services

16/01/2020 Catalent Further Strengthens Biologics Business with Key Senior Appointments

29/01/2020 Catalent Appoints Ricci Whitlow to Lead Clinical Supply Services Business

03/02/2020 Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform

10/02/2020 Vectura announces the appointment of Sharon Johnson, Executive Vice President for Delivery Management

11/02/2020 Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors

12/02/2020 Catalent Appoints Jim Walter as Vice President of Operations for Oral and Specialty Delivery

25/02/2020 Perrigo and Catalent Announce FDA Approval of Perrigo’s AB-Rated Generic Version of ProAir® HFA

27/02/2020 Catalent Announces Supplying Blueprint Medicines’ Precision Therapy AYVAKIT™ (avapritinib)

09/03/2020 Vectura appoints Mark Bridgewater as Chief Commercial Officer

17/03/2020 Catalent Partners with Biohaven on New Fast-Dissolve Migraine Treatment0

23/04/2020 Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility

29/04/2020 Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate

30/04/2020 Catalent Announces Next Generation of Cell & Gene Therapy Leadership

04/05/2020 Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

07/05/2020 Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19

13/05/2020 Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

18/05/2020 Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin’s Lymphoma

21/05/2020 Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

02/06/2020 Catalent Appoints Charles Lickfold as Chief Information Officer

03/06/2020 Vectura Expands Business Development Team with Three Global Appointments

Upcoming Events

NEPR will be attending the following events:

None at present – at this time our thoughts go out to all who have been affected by the current global situation, and we hope we will be meeting people when it is safe to do so.